154 related articles for article (PubMed ID: 12381453)
1. Sodium-iodide symporter (NIS)-mediated accumulation of [(211)At]astatide in NIS-transfected human cancer cells.
Carlin S; Mairs RJ; Welsh P; Zalutsky MR
Nucl Med Biol; 2002 Oct; 29(7):729-39. PubMed ID: 12381453
[TBL] [Abstract][Full Text] [Related]
2. In vitro cytotoxicity of (211)at-astatide and (131)I-iodide to glioma tumor cells expressing the sodium/iodide symporter.
Carlin S; Akabani G; Zalutsky MR
J Nucl Med; 2003 Nov; 44(11):1827-38. PubMed ID: 14602867
[TBL] [Abstract][Full Text] [Related]
3. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter.
Petrich T; Helmeke HJ; Meyer GJ; Knapp WH; Pötter E
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):842-54. PubMed ID: 12111124
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of
Watabe T; Kaneda-Nakashima K; Liu Y; Shirakami Y; Ooe K; Toyoshima A; Shimosegawa E; Fukuda M; Shinohara A; Hatazawa J
J Nucl Med; 2019 Sep; 60(9):1301-1307. PubMed ID: 30796173
[No Abstract] [Full Text] [Related]
5. Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, pertechnetate, and iodide by NaI symporter-expressing tissues in vivo.
Zuckier LS; Dohan O; Li Y; Chang CJ; Carrasco N; Dadachova E
J Nucl Med; 2004 Mar; 45(3):500-7. PubMed ID: 15001694
[TBL] [Abstract][Full Text] [Related]
6. Functional activity of human sodium/iodide symporter in tumor cell lines.
Petrich T; Knapp WH; Pötter E
Nuklearmedizin; 2003 Feb; 42(1):15-8. PubMed ID: 12601449
[TBL] [Abstract][Full Text] [Related]
7. Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line.
Jeong H; Kim YR; Kim KN; Choe JG; Chung JK; Kim MK
Nucl Med Biol; 2006 Oct; 33(7):875-82. PubMed ID: 17045167
[TBL] [Abstract][Full Text] [Related]
8. Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: effect on clonogenicity in both two-and three-dimensional models.
Carlin S; Cunningham SH; Boyd M; McCluskey AG; Mairs RJ
Cancer Gene Ther; 2000 Dec; 7(12):1529-36. PubMed ID: 11228531
[TBL] [Abstract][Full Text] [Related]
9. Sodium/iodide symporter gene transfection increases radionuclide uptake in human cisplatin-resistant lung cancer cells.
Chai W; Yin X; Ren L; Cai M; Long T; Zhou M; Tang Y; Yang N; Hu S
Clin Transl Oncol; 2015 Oct; 17(10):795-802. PubMed ID: 26115738
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo characteristics of a human colon cancer cell line, SNU-C5N, expressing sodium-iodide symporter.
Min JJ; Chung JK; Lee YJ; Shin JH; Yeo JS; Jeong JM; Lee DS; Bom HS; Lee MC
Nucl Med Biol; 2002 Jul; 29(5):537-45. PubMed ID: 12088723
[TBL] [Abstract][Full Text] [Related]
11. Effective cancer therapy with the alpha-particle emitter [211At]astatine in a mouse model of genetically modified sodium/iodide symporter-expressing tumors.
Petrich T; Quintanilla-Martinez L; Korkmaz Z; Samson E; Helmeke HJ; Meyer GJ; Knapp WH; Pötter E
Clin Cancer Res; 2006 Feb; 12(4):1342-8. PubMed ID: 16489092
[TBL] [Abstract][Full Text] [Related]
12. Radiation-induced thyroid stunning: differential effects of (123)I, (131)I, (99m)Tc, and (211)At on iodide transport and NIS mRNA expression in cultured thyroid cells.
Lundh C; Lindencrona U; Postgård P; Carlsson T; Nilsson M; Forssell-Aronsson E
J Nucl Med; 2009 Jul; 50(7):1161-7. PubMed ID: 19525464
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of
Jiang H; Bansal A; Goyal R; Peng KW; Russell SJ; DeGrado TR
Bioorg Med Chem; 2018 Jan; 26(1):225-231. PubMed ID: 29198608
[TBL] [Abstract][Full Text] [Related]
14. Effects of dose, intervention time, and radionuclide on sodium iodide symporter (NIS)-targeted radionuclide therapy.
Shen DH; Marsee DK; Schaap J; Yang W; Cho JY; Hinkle G; Nagaraja HN; Kloos RT; Barth RF; Jhiang SM
Gene Ther; 2004 Jan; 11(2):161-9. PubMed ID: 14712300
[TBL] [Abstract][Full Text] [Related]
15. Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy.
Kang JH; Chung JK; Lee YJ; Shin JH; Jeong JM; Lee DS; Lee MC
J Nucl Med; 2004 Sep; 45(9):1571-6. PubMed ID: 15347726
[TBL] [Abstract][Full Text] [Related]
16. Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non-small cell lung cancer.
Huang M; Batra RK; Kogai T; Lin YQ; Hershman JM; Lichtenstein A; Sharma S; Zhu LX; Brent GA; Dubinett SM
Cancer Gene Ther; 2001 Aug; 8(8):612-8. PubMed ID: 11571539
[TBL] [Abstract][Full Text] [Related]
17. Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
Min JJ; Chung JK; Lee YJ; Jeong JM; Lee DS; Jang JJ; Lee MC; Cho BY
Eur J Nucl Med; 2001 May; 28(5):639-45. PubMed ID: 11383871
[TBL] [Abstract][Full Text] [Related]
18. Cotransfected sodium iodide symporter and human tyroperoxidase genes following human telomerase reverse transcriptase promoter for targeted radioiodine therapy of malignant glioma cells.
Li W; Tan J; Wang P; Wu P
Cancer Biother Radiopharm; 2011 Aug; 26(4):443-51. PubMed ID: 21797672
[TBL] [Abstract][Full Text] [Related]
19. Visualization of hypoxia-inducible factor-1 transcriptional activation in C6 glioma using luciferase and sodium iodide symporter genes.
Yeom CJ; Chung JK; Kang JH; Jeon YH; Kim KI; Jin YN; Lee YM; Jeong JM; Lee DS
J Nucl Med; 2008 Sep; 49(9):1489-97. PubMed ID: 18703592
[TBL] [Abstract][Full Text] [Related]
20. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter.
Spitzweg C; O'Connor MK; Bergert ER; Tindall DJ; Young CY; Morris JC
Cancer Res; 2000 Nov; 60(22):6526-30. PubMed ID: 11103823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
